Lobbying Activity Report

1197-20580

Organization: Cystic Fibrosis Canada
Associated registration: 1476-1197-12
Lobbying Activity date: 2022-08-31
Arranged a meeting: No
Posted date: 2022-09-15

In-house lobbyists who participated in the lobbying activity: Kelly Grover Footnote1
Senior Public Office Holders who were lobbied in this activity: Tijana Fazlagic, Executive Director, PharmaCare Benefits Branch
Provincial Health Services Authority

Mitch Moneo, ADM, Ministry of Health, PLBSD - Pharmaceutical, Laboratory & Blood Services Division
Provincial Health Services Authority
 
Subject Matter of the Lobbying Activity
Specific Topics of Lobbying Communications Intended Outcomes Associated Subject Matters
We are calling on the BC government to ensure that CF modulator and symptom management drugs are available to all who need them. In particular, we will be calling on the BC government to fund Trikafta immediately upon Health Canada approval with the broadest prescribing criteria for those diagnosed with cystic fibrosis from age 6 plus.
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
 Health
 
Senior officer who filed this Lobbying Activity Report: Kelly Grover
 
The above name is that of the most senior paid officer who is responsible for filing a Lobbying Activity Report for the organization (the Designated Filer), whether that person participated in this lobbying activity or not.
 
  1. Footnote1  Indicates new information that was added through a Lobbying Activity Report.
Date Modified: